Since the Food and Drug Administration blasted Novartis earlier this month over data manipulation, one of the major questions looming over the matter has been why the agency came down so publicly on ...
An approaching cyber storm—one capable of unleashing unprecedented chaos—is looming on the horizon of the United States’ public and private sectors. Although experts warn that attackers are poised to ...
*A December 14 report from the House Committee on Oversight and Government Reform alleges that outgoing D.C. Police Chief Pamela A. Smith deliberately pressured her commanders to manipulate crime ...
Why did Novartis wait about two months before launching an internal probe into the alleged data manipulation surrounding gene therapy Zolgensma? That's what officials at the FDA want to know. After an ...
Hosted on MSN
AI program accused of manipulating its training data
Artificial Intelligence (AI) has become a cornerstone of the digital landscape, yet it is not without its share of controversies. A recent case has brought to light accusations of an AI program ...
AveXis, the gene-therapy subsidiary of Novartis, is being investigated by the US Food and Drug Administration for manipulating data related to its recently approved gene therapy Zolgensma. AveXis told ...
In a statement issued Tuesday, Peter Marks, director of the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research (CBER), said the agency is investigating data ...
GLENDALE, Colo. — A deputy director for the state health department’s water quality lab resigned as they were about to be punished for not acting on information about a chemist who manipulated data, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results